- •PROGRESS IN BRAIN RESEARCH
- •List of Contributors
- •Preface
- •Epidemiology of primary glaucoma: prevalence, incidence, and blinding effects
- •Introduction
- •Prevalence of glaucoma
- •PAC suspect
- •PACG
- •Incidence of glaucoma
- •Blinding effects of glaucoma
- •Abbreviations
- •Acknowledgment
- •References
- •Predictive models to estimate the risk of glaucoma development and progression
- •Risk assessment in ocular hypertension and glaucoma
- •Risk factors for glaucoma development
- •Intraocular pressure
- •Corneal thickness
- •Cup/disc ratio and pattern standard deviation
- •The need for predictive models
- •Predictive models for glaucoma development
- •Predictive models for glaucoma progression
- •Limitations of predictive models
- •References
- •Intraocular pressure and central corneal thickness
- •Main text
- •References
- •Angle-closure: risk factors, diagnosis and treatment
- •Introduction
- •Mechanism
- •Other causes of angle closure
- •Risk factors
- •Age and gender
- •Ethnicity
- •Ocular biometry
- •Genetics
- •Diagnosis
- •Acute primary angle closure
- •Angle assessment in angle closure
- •Gonioscopy technique
- •Ultrasound biomicroscopy (UBM)
- •Scanning peripheral anterior chamber depth analyzer (SPAC)
- •Management
- •Acute primary angle closure
- •Medical therapy
- •Argon laser peripheral iridoplasty (ALPI)
- •Laser peripheral iridotomy (PI)
- •Lens extraction
- •Monitoring for subsequent IOP rise in eyes with APAC
- •Fellow eye of APAC
- •Chronic primary angle-closure glaucoma (CACG)
- •Laser peripheral iridotomy
- •Laser iridoplasty
- •Medical therapy
- •Trabeculectomy
- •Lens extraction
- •Combined lens extraction and trabeculectomy surgery
- •Goniosynechialysis
- •Summary
- •List of abbreviations
- •References
- •Early diagnosis in glaucoma
- •Introduction
- •History and examination
- •Quantitative tests and the diagnostic process
- •Pretest probability
- •Test validity
- •Diagnostic test performance
- •Posttest probability
- •Combing test results
- •Selective tests of visual function
- •Early glaucoma diagnosis from quantitative test results
- •Progression to make a diagnosis
- •Conclusions
- •Abbreviations
- •References
- •Monitoring glaucoma progression
- •Introduction
- •Monitoring structural damage progression
- •Monitoring functional damage progression
- •Abbreviations
- •References
- •Standard automated perimetry and algorithms for monitoring glaucoma progression
- •Standard automated perimetry
- •Global indices
- •HFA: MD, SF, PSD, CPSD
- •Octopus indices: MD, SF, CLV
- •OCTOPUS seven-in-one report (Fig. 2)
- •SAP VF assessment: full-threshold strategy
- •SAP VF defects assessment: OHTS criteria
- •SAP VF defects assessment: AGIS criteria
- •SAP VF defects assessment: CIGTS
- •Fastpac
- •Swedish interactive threshold algorithm
- •SAP VF assessment: the glaucoma staging system
- •SAP: interocular asymmetries in OHTS
- •SAP, VF progression
- •SAP: the relationship to other functional and structural diagnostic tests in glaucoma
- •SAP, FDP-Matrix
- •SAP, SWAP, HPRP, FDT
- •SAP: the relationship between function and structure
- •SAP, confocal scanning laser ophthalmoscopy, SLP-VCC
- •SAP, optical coherence tomography
- •SAP and functional magnetic resonance imaging
- •References
- •Introduction
- •Retinal ganglion cells: anatomy and function
- •Is glaucoma damage selective for any subgroup of RGCs?
- •Segregation
- •Isolation
- •FDT: rationale and perimetric techniques
- •SWAP: rationale and perimetric techniques
- •FDT: clinical data
- •SWAP: clinical data
- •Clinical data comparing FDT and SWAP
- •Conclusions
- •References
- •Scanning laser polarimetry and confocal scanning laser ophthalmoscopy: technical notes on their use in glaucoma
- •The GDx scanning laser polarimeter
- •Serial analysis
- •Limits
- •The Heidelberg retinal tomograph
- •Limits
- •Conclusions
- •References
- •The role of OCT in glaucoma management
- •Introduction
- •How OCT works
- •How OCT is performed
- •Evaluation of RNFL thickness
- •Evaluation of optic disc
- •OCT in glaucoma management
- •New perspective
- •Abbreviations
- •References
- •Introduction
- •Technology
- •Visual stimulation
- •Reproducibility and habituation of RFonh
- •Retinal neural activity as assessed from the electroretinogram (ERG)
- •The Parvo (P)- and Magno (M)-cellular pathways
- •Physiology
- •Magnitude and time course of RFonh in humans
- •Varying the parameters of the stimulus on RFonh
- •Luminance versus chromatic modulation
- •Frequency
- •Effect of pattern stimulation
- •Neurovascular coupling in humans
- •Clinical application
- •RFonh in OHT and glaucoma patients
- •Discussion
- •FLDF and neurovascular coupling in humans
- •Comments on clinical application of FLDF in glaucoma
- •Conclusions and futures directions
- •Acknowledgements
- •References
- •Advances in neuroimaging of the visual pathways and their use in glaucoma
- •Introduction
- •Conventional MR imaging and the visual pathways
- •Diffusion MR imaging
- •Functional MR imaging
- •Proton MR spectroscopy
- •References
- •Primary open angle glaucoma: an overview on medical therapy
- •Introduction
- •When to treat
- •Whom to treat
- •Genetics
- •Race
- •Ocular and systemic abnormalities
- •Tonometry and pachymetry
- •How to treat
- •Beta-blockers
- •Prostaglandins
- •Alpha-agonists
- •Carbonic anhydrase inhibitors (CAIs)
- •Myotics
- •Fixed combinations
- •References
- •The treatment of normal-tension glaucoma
- •Introduction
- •Epidemiology
- •Clinical features
- •Optic disk
- •Central corneal thickness
- •Disease course
- •Risk factors
- •Intraocular pressure
- •Local vascular factors
- •Immune mechanisms
- •Differential diagnosis
- •Diagnostic evaluation
- •Therapy
- •IOP reduction
- •Systemic medications
- •Neuroprotection
- •Noncompliance
- •Genetics of NTG
- •Abbreviations
- •References
- •The management of exfoliative glaucoma
- •Introduction
- •Epidemiology
- •Ocular and systemic associations
- •Ocular associations
- •Systemic associations
- •Pathogenesis of exfoliation syndrome
- •Mechanisms of glaucoma development
- •Management
- •Medical therapy
- •Laser surgery
- •Operative surgery
- •Future treatment of exfoliation syndrome and exfoliative glaucoma
- •Treatment directed at exfoliation material
- •References
- •Laser therapies for glaucoma: new frontiers
- •Background
- •Laser iridotomy
- •Indications
- •Contraindications
- •Patient preparation
- •Technique
- •Nd:YAG laser iridectomy
- •Argon laser iridectomy
- •Complications
- •LASER trabeculoplasty
- •Treatment technique
- •Mechanism of action
- •Indications for treatment
- •Contraindications to treatment
- •Patient preparation and postoperative follow-up
- •Complications of the treatment
- •Selective laser trabeculoplasty
- •Results
- •LASER iridoplasty
- •Indications
- •Contraindications
- •Treatment technique
- •Complications
- •LASER cyclophotocoagulation
- •Introduction
- •Indications and contraindications
- •Patient preparation
- •Transpupillary cyclophotocoagulation
- •Endoscopic cyclophotocoagulation
- •Transscleral cyclophotocoagulation
- •Transscleral noncontact cyclophotocoagulation
- •Transscleral contact cyclophotocoagulation
- •Complications
- •Excimer laser trabeculotomy
- •References
- •Modulation of wound healing during and after glaucoma surgery
- •The process of wound healing
- •Using surgical and anatomical principles to modify therapy
- •Growth factors
- •Cellular proliferation and vascularization
- •Cell motility, matrix contraction and synthesis
- •Drug delivery
- •Future directions: total scarring control and tissue regeneration
- •Acknowledgments
- •References
- •Surgical alternative to trabeculectomy
- •Introduction
- •Deep sclerectomy
- •Viscocanalostomy
- •Conclusions
- •References
- •Modern aqueous shunt implantation: future challenges
- •Background
- •Current shunts and factors affecting their function
- •Shunt-related factors
- •Surface area
- •Plate material
- •Valved versus non-valved
- •Commercially available devices
- •Comparative studies
- •Patient and ocular factors
- •Severity of glaucoma damage
- •Tolerance of topical ocular hypotensive medications
- •Aqueous hyposecretion
- •Previous ocular surgery
- •Scleral thinning
- •Patient cooperation for and tolerance of potential slit-lamp interventions
- •Future challenges
- •Predictability
- •Cataract formation
- •The long-term effect on the cornea
- •References
- •Model systems for experimental studies: retinal ganglion cells in culture
- •Mixed RGCs in culture
- •Retinal explants
- •Glial cultures
- •RGC-5 cells
- •Differentiation of RGC-5 cells
- •RGC-5 cell neurites
- •Advantages and disadvantages of culture models
- •References
- •Rat models for glaucoma research
- •Rat models for glaucoma research
- •Use of animal models for POAG
- •Suitability of the rat for models of optic nerve damage in POAG
- •Methods for measuring IOP in rats
- •General considerations for measuring IOP in rats
- •Assessing optic nerve and retina damage
- •Experimental methods of producing elevated IOP
- •Laser treatment of limbal tissues
- •Episcleral vein cautery
- •Conclusions
- •Abbreviations
- •Acknowledgements
- •References
- •Mouse genetic models: an ideal system for understanding glaucomatous neurodegeneration and neuroprotection
- •Introduction
- •The mouse as a model system
- •Mice are suitable models for studying IOP elevation in glaucoma
- •Tools for glaucoma research
- •Accurate IOP measurements are fundamental to the study of glaucoma
- •The future of IOP assessment
- •Assessment of RGC function
- •Mouse models of glaucoma
- •Primary open-angle glaucoma
- •MYOC
- •OPTN
- •Strategies for developing new models of POAG
- •Developmental glaucoma
- •Pigmentary glaucoma
- •Experimentally induced models of glaucoma
- •Mouse models to characterize processes involved in glaucomatous neurodegeneration
- •Similar patterns of glaucomatous damage occur in humans and mice
- •The lamina cribrosa is an important site of early glaucomatous damage
- •An insult occurs to the axons of RGCs within the lamina in glaucoma
- •What is the nature of the insult at the lamina?
- •Other changes occur in the retina in glaucoma
- •PERG and complement
- •Using mouse models to develop neuroprotective strategies
- •Somal protection
- •Axonal protection
- •Erythropoietin administration
- •Radiation-based treatment
- •References
- •Clinical trials in neuroprotection
- •Introduction
- •Methods of clinical studies
- •Issues in the design and conduct of clinical trials
- •Clinical trials of neuroprotection
- •Clinical trials of neuroprotection in ophthalmology
- •Endpoints
- •Neuroprotection and glaucoma
- •Conclusions
- •Abbreviations
- •References
- •Pathogenesis of ganglion ‘‘cell death’’ in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria
- •Introduction
- •Retinal ganglion cells and mitochondria
- •Possible causes for ganglion cell death in glaucoma
- •Mitochondrial functions and apoptosis
- •Mitochondrial function enhancement and the attenuation of ganglion cell death
- •Creatine
- •Nicotinamide
- •Epigallocatechin gallate
- •Conclusion
- •References
- •Astrocytes in glaucomatous optic neuropathy
- •Introduction
- •Quiescent astrocytes
- •Reactive astrocytes in glaucoma
- •Signal transduction in glaucomatous astrocytes
- •Protein tyrosine kinases (PTKs)
- •Serine/threonine protein mitogen-activated kinases (MAPKs)
- •G protein-coupled receptors
- •Ras superfamily of small G proteins
- •Astrocyte migration in the glaucomatous optic nerve head
- •Cell adhesion of ONH astrocytes
- •Connective tissue changes in the glaucomatous optic nerve head
- •Extracellular matrix synthesis by ONH astrocytes
- •Extracellular matrix degradation by reactive astrocytes
- •Oxidative stress in ONH astrocytes
- •Conclusions
- •Acknowledgments
- •References
- •Glaucoma as a neuropathy amenable to neuroprotection and immune manipulation
- •Glaucoma as a neurodegenerative disease
- •Oxidative stress and free radicals
- •Excessive glutamate, increased calcium levels, and excitotoxicity
- •Deprivation of neurotrophins and growth factors
- •Abnormal accumulation of proteins
- •Pharmacological neuroprotection for glaucoma
- •Protection of the retinal ganglion cells involves the immune system
- •Searching for an antigen for potential glaucoma therapy
- •Concluding remarks
- •References
- •Oxidative stress and glaucoma: injury in the anterior segment of the eye
- •Introduction
- •Oxidative stress
- •Trabecular meshwork
- •IOP increase and free radicals
- •Glaucomatous cascade
- •Nitric oxide and endothelins
- •Extracellular matrix
- •Metalloproteinases
- •Other factors of interest
- •Therapeutic and preventive substances of interest in glaucoma
- •Ginkgo biloba extract
- •Green tea
- •Ginseng
- •Memantine and its derivates
- •Conclusions
- •Abbreviations
- •References
- •Conclusions on neuroprotective treatment targets in glaucoma
- •Acknowledgments
- •References
- •Involvement of the Bcl2 gene family in the signaling and control of retinal ganglion cell death
- •Introduction
- •Intrinsic apoptosis vs. extrinsic apoptosis
- •The Bcl2 family of proteins
- •The requirement of BAX for RGC soma death
- •BH3-only proteins and the early signaling of ganglion cell apoptosis
- •Conclusion
- •Abbreviations
- •Acknowledgments
- •References
- •Assessment of neuroprotection in the retina with DARC
- •Introduction
- •DARC
- •Introducing the DARC technique
- •Annexin 5-labeled apoptosis and ophthalmoloscopy
- •Detection of RGC apoptosis in glaucoma-related animal models with DARC
- •Assessment of glutamate modulation with DARC
- •Glutamate at synaptic endings
- •Glutamate excitotoxicity in glaucoma
- •Assessment of coenzyme Q10 in glaucoma-related models with DARC
- •Summary
- •Abbreviations
- •Acknowledgment
- •References
- •Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection
- •Introduction
- •The endocannabinoid system in the eye
- •The IOP-lowering effects of endocannabinoids
- •Endocannabinoids and neuroprotection
- •Conclusions
- •References
- •Glaucoma of the brain: a disease model for the study of transsynaptic neural degeneration
- •Retinal ganglion cells, retino-geniculate neurons
- •Lateral geniculate nucleus
- •Mechanisms of RGC injury in glaucoma
- •Transsynaptic degeneration of the lateral geniculate nucleus in glaucoma
- •Neural degeneration in magno-, parvo-, and koniocellular LGN layers
- •Visual cortex in glaucoma
- •Neuropathology of glaucoma in the visual pathways in the human brain
- •Mechanisms of glaucoma damage in the central visual pathways
- •Implications of central visual system injury in glaucoma
- •Conclusion
- •Acknowledgments
- •References
- •Clinical relevance of optic neuropathy
- •Is there a remodeling of retinal circuitry?
- •Behavioral consequences of glaucoma
- •Glaucoma as a neurodegenerative disease versus neuroplasticity and adaptive changes
- •Future directions
- •Acknowledgment
- •References
- •Targeting excitotoxic/free radical signaling pathways for therapeutic intervention in glaucoma
- •Introduction
- •Channel properties of NMDA receptors correlated with excitotoxicity
- •Downstream signaling cascades after overactivation of NMDA receptors
- •Relevance of excitotoxicity to glaucoma
- •Therapeutic approaches to prevent RGC death by targeting the pathways involved in NMDA excitotoxicity
- •Drugs targeting NMDA receptors
- •Kinetics of NMDA receptor antagonists
- •Memantine
- •NitroMemantines
- •Drugs targeting downstream signaling molecules in NMDA-induced cell death pathways
- •p38 MAPK inhibitors
- •Averting caspase-mediated neurodegeneration
- •Abbreviations
- •Acknowledgments
- •References
- •Stem cells for neuroprotection in glaucoma
- •Introduction
- •Glaucoma as a model of neurodegenerative disease
- •Why use stem cells for neuroprotective therapy?
- •Stem cell sources
- •Neuroprotection by transplanted stem cells
- •Endogenous stem cells
- •Key challenges
- •Conclusion
- •Abbreviations
- •Acknowledgments
- •References
- •The relationship between neurotrophic factors and CaMKII in the death and survival of retinal ganglion cells
- •Introduction
- •Glaucoma and the RGCs
- •Are other retinal cells affected in glaucoma?
- •Retinal ischemia related glaucoma
- •Excitotoxicity and the retina
- •Signal transduction
- •NMDA receptor antagonists and CaMKII
- •Caspase-3 activation in NMDA-induced retinal cell death and its inhibition by m-AIP
- •BDNF and neuroprotection of RGCs
- •Summary and conclusions
- •Abbreviations
- •Acknowledgments
- •References
- •Evidence of the neuroprotective role of citicoline in glaucoma patients
- •Introduction
- •Patients: selection and recruitment criteria
- •Pharmacological treatment protocol
- •Methodology of visual function evaluation: electrophysiological examinations
- •PERG recordings
- •VEP recordings
- •Statistic evaluation of electrophysiological results
- •Electrophysiological (PERG and VEP) responses in OAG patients after the second period of evaluation
- •Effects of citicoline on retinal function in glaucoma patients: neurophysiological implications
- •Effects of citicoline on neural conduction along the visual pathways in glaucoma patients: neurophysiological implications
- •Possibility of neuroprotective role of citicoline in glaucoma patients
- •Conclusive remarks
- •Abbreviations
- •References
- •Neuroprotection: VEGF, IL-6, and clusterin: the dark side of the moon
- •Neuroprotection: VEGF-A, a shared growth factor
- •VEGF-A isoforms
- •VEGF-A receptors
- •Angiogenesis, mitogenesis, and endothelial survival
- •Neurotrophic and neuroprotective effect
- •Intravitreal VEGF inhibition therapy and neuroretina toxicity
- •Neuroprotection: clusterin, a multifunctional protein
- •Clusterin/ApoJ: a debated physiological role
- •Clusterin and diseases
- •Clusterin and the nervous system
- •Neuroprotection: IL-6, VEGF, clusterin, and glaucoma
- •Rational basis for the development of coenzyme Q10 as a neurotherapeutic agent for retinal protection
- •Introduction
- •Ischemia model
- •Neuroprotective effect of Coenzyme Q10 against cell loss yielded by transient ischemia in the RGC layer
- •Retinal ischemia and glutamate
- •Coenzyme Q10 minimizes glutamate increase induced by ischemia/reperfusion
- •Summary
- •Acknowledgment
- •References
- •17beta-Estradiol prevents retinal ganglion cell loss induced by acute rise of intraocular pressure in rat
- •Methods
- •Morphometric analysis
- •Microdialysis
- •Drug application
- •Statistical analysis
- •Results
- •17beta-Estradiol pretreatment minimizes RGC loss
- •Discussion
- •Acknowledgment
C. Nucci et al. (Eds.)
Progress in Brain Research, Vol. 173
ISSN 0079-6123
Copyright r 2008 Elsevier B.V. All rights reserved
CHAPTER 12
Advances in neuroimaging of the visual pathways and their use in glaucoma
Francesco Giuseppe Garaci1,2, , Valeria Cozzolino1, Carlo Nucci3, Fabrizio Gaudiello1, Andrea Ludovici1, Tommaso Lupattelli4, Roberto Floris1 and Giovanni Simonetti1
1Department of Diagnostic Imaging and Interventional Radiology, University of Rome ‘‘Tor Vergata,’’ V.le Oxford 81, Rome, Italy
2IRCCS San Raffaele Pisana, Via della Pisana 235, Rome, Italy 3Physiopathological Optics, Department of Biopathology, University of Rome Tor Vergata, Rome, Italy
4Interventional Radiology Department, IRCCS Multimedica, Sesto San Giovanni, Milan, Italy
Abstract: Recently developed neuroimaging techniques such as diffusion tensor (DT) magnetic resonance (MR) imaging, functional MR imaging (fMRI), and MR spectroscopy can be used to evaluate the microstructural integrity of white-matter fibers and the functional activity of gray matter. They have been widely employed to investigate various diseases of the central nervous system, and they can be useful tools for assessing the integrity and functional connections of the visual pathways and areas that play key roles in glaucoma. In vivo degeneration of the optic nerves can be noninvasively demonstrated by DT MR imaging. DT fiber tractography provides valuable information on the axonal density of postgeniculate fibers (optic radiation), and fMRI studies of patients with primary open-angle glaucoma (POAG) have demonstrated alterations involving the human visual cortex that are consistent with clinically documented losses of visual function. This article reviews some of the more recent data supporting the use of MR imaging techniques as reliable, noninvasive tools for monitoring the progression of human glaucoma.
Keywords: MRI; diffusion tensor imaging; functional MR imaging; tractography; glaucoma
Introduction
Recently developed neuroimaging techniques such as diffusion tensor (DT) magnetic resonance (MR) imaging and functional MR imaging (fMRI) can be used to evaluate the microstructural integrity of white-matter fibers and the functional activity of gray matter. Their introduction has allowed a reexploration of the normal anatomy of
Corresponding author. Tel.: +39 06 2090 2401; Fax: +39 06 2090 2404; E-mail: garaci@gmail.com
white-matter tracts in the living human brain and the elaboration of connectional models of brain function. During the last 10 years, these techniques have also been used for the in vivo study of a variety of brain pathologies. First used in the investigation of ischemic stroke, they are now becoming increasingly important in the evaluation of intracranial neoplasms, inflammatory disorders, developmental anomalies of the central nervous system (CNS), and neurodegenerative diseases.
Both techniques can also be utilized to investigate the integrity and functional connections of the visual pathways, including areas that play key
DOI: 10.1016/S0079-6123(08)01112-6 |
165 |
166
roles in glaucoma: preand postgeniculate whitematter fibers, the lateral geniculate nuclei (LGNs), and various areas of the visual cortex. This article provides an overview of some of the newer MRI techniques being used in neuro-ophthalmology and their specific applications in the study of patients with glaucoma.
Conventional MR imaging and the visual pathways
The macroscopic anatomy of the visual system can be demonstrated and assessed in vivo with conventional MR imaging. The optic nerve is a whitematter tract that is sheathed by the leptomeninges and dura mater, and its subarachnoid space is continuous with the intracranial subarachnoid space. On oblique coronal MR images, the intraorbital segment of the optic nerve ranges in thickness from 3.1 (anteriorly) to 2.5 mm (posteriorly), whereas the mean dural diameter measures between 5.1 (anteriorly) and 3.8 mm (posteriorly). The width of the subarachnoid space between the pial and dural sheaths ranges from 0.4 to 0.6 mm.
The optic nerve itself can be divided into intraocular, intraorbital, intracanalicular, and intracranial segments. The intraorbital tract, which is approximately 3 cm long, follows a sinuous course in both the horizontal and vertical planes. The intracanalicular portion is about 8 mm long. It passes through the optic canal (the channel at the apex of the orbital cavity) and the anterior end of the optic groove, which lies just below the lesser wing of the sphenoid bone. The ophthalmic artery runs through the same canal. The two optic nerves emerge from the optic foramina, ascend at an angle of approximately 451, and join to form the optic chiasm, which lies beneath the floor of the third ventricle, approximately 10 mm above the diaphragma sella.
The orbit is lined with adipose tissue, which is well organized and divided by fibrovascular septa. The contrast that makes the orbital structures stand out on an MR image is produced by this fat, which is associated with high signal intensity on T1-weighted images and high signal intensity on conventional T2-weighted images.
The anatomy of the optic nerve can be studied on an inversion recovery T1-weighted volume set,
which has a high signal-to-noise ratio, provides excellent contrast resolution, and can be reformatted in several planes. Use of this sequence facilitates differentiation of the optic nerve from the adipose tissue that surrounds it. The macroscopic anatomy can be better visualized on axial, coronal, and oblique–sagittal (along the long axis of the optic nerve) reconstructions with thin thickness and no gaps between the sections (Fig. 1). T2-weighted images can also be used to study the normal anatomy of the optic nerve (Fig. 2), but they are more useful for excluding the presence of lesions and/or atrophy. In the presence of optic nerve atrophy, the volume of the cerebrospinal fluid surrounding the nerve (which produces high-intensity signals on T2-weighted images) is increased. Again, T1-weighted images are helpful for visualizing the anatomy of the chiasm and for assessment of post-contrast enhancement on fat-suppressed images (Fig. 3).
The optic tracts are visualized using the same method. A three-dimensional T2-weighted sequence can also be used to image the structures in and around the optic chiasm, thanks to the natural contrast furnished by the abundant cerebrospinal fluid in the chiasmatic cistern (Fig. 4). The optic tract segments close to the LGN are difficult to visualize on morphological sequences owing to the partial volume effect produced by the intraaxial brain structures. T1-weighted inversion recovery images are also used to identify the LGNs based on the contrast between the MR signals generated by gray and white matter. Postgeniculate fibers are not visualized with conventional morphological imaging because these sequences can only distinguish brain structures characterized by ‘‘natural contrast’’ (e.g., white vs. gray matter, nerves vs. CSF) (Jacobs and Galetta, 2007).
For distinguishing the white-matter fibers and mapping the visual gray matter areas (LGN and cortex), the functional neuroimaging modalities discussed below (diffusion-weighted MR and fMRI) are valuable tools.
Diffusion MR imaging
Diffusion is a random process that results from the thermal translational motion of molecules. In
Fig. 1. Conventional axial (A) and coronal (B) T1-weighted images demonstrating the macroscopic anatomy of the intraorbital portion of the optic nerve. Note the hyperintense signal of intraorbital adipose tissue lining the nerves and the hypointense signal from the extraocular muscles.
biological tissues, water diffuses inside, outside, around, and through cellular structures. Cellular membranes hinder these movements and force the water to take more tortuous paths. Diffusion is restricted by the presence of cellular swelling or increased cellularity, whereas necrosis, which involves the breakdown of cellular membranes,
167
Fig. 2. Conventional morphological axial (A) and coronal (B) T2-weighted images obtained by using a 3 T magnet showing the intraorbital segment of optic nerves.
decreases diffusion-path tortuosity and increases apparent diffusivity (Le Bihan, 1995). Studies of water diffusion can thus provide information on cellular integrity and pathology. In conventional MR imaging, the effect of diffusion contributes very little to the overall signal intensity. As the diffusing protons move through intrinsic and extrinsic magnetic field gradients, they experience phase shifts that result in a loss of transverse
168
Fig. 3. Sagittal T1-weighted image (A) showing the chiasmatic region and the optic tract (arrow); (B) Post-contrast axial T1weighted image with fat-suppression technique, note the normal enhancement of the extraocular muscles (long arrow) and the absence of enhancement of the optic nerve (thick arrow).
magnetization. This phenomenon is exploited to create diffusion maps, which represent the spatial distribution of diffusion coefficients for the imaged tissue. An early study on the diffusivity of whitematter fibers in normal subjects showed that the apparent diffusion coefficients (ADC) are dependent on the orientation of the diffusion gradients
with respect to the tracts being examined (Hajnal et al., 1991). Fiber tracts lying parallel to an applied gradient have the highest ADC, and the lowest coefficients are observed with tracts that lie transverse or oblique to a sensitizing gradient. This observation highlighted the importance of directionality in the assessment of diffusing molecules. The diffusion of water molecules (especially in white matter) does not proceed equally in all directions: it is anisotropic, i.e., characterized by the predominance of movement in one direction (Basser, 1995).
Diffusion-weighted MR imaging has found numerous applications in the field of neuroscience, including the evaluation of stroke, brain development, tumors, and demyelinating disorders. The most common approach is to obtain an echoplanar sequence with supplementary diffusion-sensitive gradients in at least three main axes in space (xx, yy, zz). Two strong gradients of opposite polarity are applied with a short interval in between. All stationary spins are equally dephased and rephased by the action of these gradients. Spins moving between the two gradients are subjected to the effects of a different field at the time of the second application. Their phase recovery is thus incomplete, and the result is signal attenuation. The sensitivity of the sequence to microscopic motion such as the diffusion of water is related to the strength and the duration of the applied gradients, which are collectively expressed by the b-value. In general, a b-value of about 800–1000 s/mm2 is used. Acquisition of a diffusion-weighted image is always accompanied by the acquisition of a reference image with a b-value of 0 (no applied diffusion gradients). The latter consists of an echoplanar image weighted in T2 (Fig. 5A).
The final signal produced by the water molecules depends on their ability to diffuse within a tissue: increased diffusion is reflected by a reduction in the intensity of the tissue signal. This phenomenon can be exploited to quantify the diffusivity of water molecules in different directions. The prevalence of diffusion in one direction, for example, along the course of white-matter fibers — diffusion anisotropy — can be quantified by calculation of a second-order symmetric tensor of six elements (or diffusivities) (Moseley et al., 1990; Conturo et al.,
169
Fig. 4. Set of coronal T2-weighted images from a three-dimensional sequence showing the prechiasmatic segment of the optic nerve (long white arrow), chiasm (thick white arrow), optic tracts (short black arrow), and pregeniculate segment of the optic tract (long black arrow).
1999). The information derived from this DT can be used to elaborate quantitative maps (Fig. 5B–D) showing mean diffusivity (MD) and fractional anisotropy (FA), which are useful for comparing individuals or populations. Anisotropy data can also be used to deduce the pathways of major nervefiber tracts, a technique known as tractography.
Diffusion tensor imaging (DTI) has been used to assess axonal degeneration within the visual pathways. Trip et al. (2006) found that MD is significantly increased and FA is significantly reduced in optic nerves affected by optic neuritis (compared with unaffected contralateral nerves and with those of healthy controls). These findings, which appeared compatible with the presence of axonal disruption, were similar to
those reported in studies of chronic brain lesions in multiple sclerosis (Werring et al., 1999; Filippi and Inglese, 2001; Dong et al., 2004). Correlation between clinical and electrophysiological parameters and diffusion-weighted MR data has been observed in optic nerves with chronic postinflammatory lesions (Hickman et al., 2005).
Postmortem histological studies have demonstrated that a lesion located between the retina and lateral geniculate body can cause full-length degeneration of the retinal ganglion cell (RGC) axons that develops in both the anterograde and retrograde directions (Hoyt and Luis, 1962). Ueki et al. (2006) used a PROPELLER (periodically rotated overlapping parallel lines with enhanced reconstruction) sequence (Pipe et al., 2002) to
170
Fig. 5. Set of diffusion images, axial plane. (A) Non-weighted image b ¼ 0; (B) mean diffusivity (MD) map; (C) fractional anisotropy (FA); (D) color map showing the direction of the fibers: green, fronto-occipital; blue, cranio-caudal; red, lateral.
obtain diffusion-weighted images of the visual pathway and found that increased diffusivity was the main alteration associated with RGC degeneration. Recently, Wu et al. (2007) demonstrated that diffusion changes are closely correlated with the total axolemmal cross-sectional area of the prechiasmatic segment of the murine optic nerve. These quantitative histological data confirm that optic nerve diffusivity is a reliable quantitative index of ultrastrucural axonal degeneration.
Irreversible degeneration of the optic nerve axons has been demonstrated in glaucoma (Nickells, 1996; Artes and Chauhan, 2005). DTI of the optic nerve in rats has revealed that FA decreases and MD increases with time after the experimental induction of glaucoma (Hui et al., 2007). The changes observed on DTI in this study
were associated with histological evidence of reductions in the number of RGC axons in the glaucomatous optic nerve. (The loss of these axons results in an expansion of the extracellular space, which enhances diffusion.) In a study being conducted by our group, DTI changes are also being found in the optic nerves of patients with different degrees of glaucoma, and these changes seem to be significantly correlated with those of the Humphrey field analysis. These data suggest that MR imaging could be a reliable, noninvasive tool for monitoring the progression of human glaucoma based on quantitative assessments of axonal loss.
DT tractography is a more recently developed technique, which can disclose the complex arrangement of fiber tracts and provide
fundamental information on cerebral connectivity (Fig. 6). It requires calculation of various parameters of the DT ellipsoid, a graphical representation of the DT within each voxel that highlights the three-dimensional character of diffusion directionality. One of the most important is the direction of the largest eigenvector (l1), i.e., the direction of greatest diffusivity, which is generally assumed to coincide with that of the fiber bundles (Mori et al., 1999; Masutani et al., 2003). In DT ellipsoid-based fiber tractography, the path of a reconstructed fiber is determined by the l1 in each voxel. Tractography usually models the water diffusion characteristics within each voxel using the DT and assumes that the tensor field within and across voxels reflects the underlying axonal architecture (Basser and Pierpaoli, 1996). In this manner, white matter can be parcellated into fiber
171
structures containing similarly oriented axonal fascicles (Mori and van Zijl, 2002).
DT fiber tractography can be used to visualize the longitudinal direction of the optic nerve fibers (Figs. 6 and 7), to depict the optic radiation (also known as the geniculocalcarine tract) (Yamamoto et al., 2007), and to assess the axonal density of postgeniculate fibers (Figs. 8 and 9).
The optic radiation consists of a broad, thin layer of fiber tracts that extend from the LGN to the primary visual cortex (which corresponds to Brodmann area 17) and are organized into anterior, central, and posterior bundles. The anterior bundle runs in an anterolateral direction and then sweeps forward and courses along the inferior horn of the lateral ventricle in the temporal lobe, thus forming the Meyer loop. It then runs posteriorly, along the lateral wall of the
Fig. 6. Reconstructed diffusion tensor fiber tractography of the optic nerves (short arrow), chiasm and the optic tracts (long arrow). (See Color Plate 12.6 in color plate section.)
172
ventricle, and projects into the lower lip of the calcarine fissure. The central bundle runs in a lateral direction and then curves posteriorly, continuing along the lateral wall of the ventricle and converging on the calcarine cortex. The
Fig. 7. Visual pathways tractography with superimposed morphological T2-weighted image at the level of the chiasm.
posterior bundle runs posteriorly along the roof of the lateral ventricle to the upper lip of the calcarine fissure. There are numerous anatomical variations in the course of the optic radiation, especially in the Meyer loop (Yamamoto et al., 2005). Knowledge of the exact course of the optic radiation in individual patients is important for predicting the outcome of visual field defects caused by temporal lobe damage and for planning neurosurgical procedures that will minimize injury to this critical tract.
Using the fiber-tracking method, Yamamoto et al. (2005) clearly depicted the three bundles of the optic radiation, from their origins in the LGN all the way to the calcarine fissure. Their findings show good agreement with those of classic anatomic studies of visual pathway topography, especially those regarding the courses of the central and posterior bundles (Ebeling and Reulen, 1988). On T2-weighted coronal sections passing through the trigonum, the optic radiation lay 2–3 mm lateral to the wall of the ventricle, which is consistent with previous reports indicating that the
Fig. 8. Optic radiation tractography (long arrow) and relation with other white-matter bundles (fronto-occipital fibers, short arrow).
